Virtual Physical Activity Seated Exercise - Phase 2
Launched by UNIVERSITY OF BRITISH COLUMBIA · Feb 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Virtual Physical Activity Seated Exercise - Phase 2, is exploring whether online seated exercise programs can help individuals who have experienced a stroke improve their balance, mobility, quality of life, and overall health. Participants in the study will be divided into two groups: one will take part in a 10-week seated exercise program, while the other will join a 2-week Boot Camp program later. All sessions and assessments will be done online, making it convenient for participants to engage from home.
To be eligible for this trial, participants must be adults who had a stroke more than six months ago and have difficulty moving around, often needing a walking aid. They should be able to stand up from a chair and complete 60 minutes of exercise safely. Participants need to be comfortable using a computer or tablet and have internet access to join the virtual sessions. However, those currently involved in other exercise programs, or who have severe health issues that limit their ability to participate, will not be eligible. This study aims to see if these seated exercises can be a helpful and accessible way for stroke survivors to stay active and improve their well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Participants must meet the following inclusion criteria:
- • Adult (as defined by Province)
- • Chronic stroke (more than 6 months post-stroke)
- • Ability to stand up from a chair
- • Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)
- • Able to safely engage in exercise and tolerate 60 minutes of exercises
- • Able to communicate in English
- • Have access to a tablet, computer, or laptop with internet and email access
- Exclusion Criteria:
- Participants will be excluded if they meet any of the following criteria:
- • Participating in formal exercise or rehabilitation activities
- • Participating in \> 30 minutes/day of physical activity (moderate intensity)
- • Participating in another study that may affect outcomes to this study
- • Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software
- • A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)
- • Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saskatoon, Saskatchewan, Canada
Vancouver, British Columbia, Canada
Winnipeg, Manitoba, Canada
London, Ontario, Canada
Halifax, Nova Scotia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials